Abstract
In allergic reactions a more or less stereotyped response follows contact of a sensitive tissue with a specific substance — the allergen. Allergens are not always chemically defined compounds, consisting as they do of either proteins or other macromolecules, foreign to the body, or modified by acting as haptens. An almost infinite variety of substances can, in susceptible individuals, act as allergens; the response of these individuals is relatively limited, consisting as it usually does of a recognizable clinical syndrome such as asthma, rhinitis, eczema, other rashes or anaphylactic shock. It is a fundamental feature of allergic disease that the nature of the clinical manifestation is not specific to the allergen. The common response can be mimicked in certain respects by administration of endogenous pharmacological agents to normal subjects. Histamine pricked into the skin, for example, causes a weal and flare reaction very similar to that seen in allergic individuals responding to prick tests with appropriate allergens. Such observations led to the idea that histamine and other endogenously released chemical mediators may be involved in various types of allergic reaction1 This has proved a quite fruitful approach, particularly in the case of Type I, anaphylactic reactions. It has thrown some light on the action of drugs effective in allergy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lewis, T. (1927). The Blood Vessels of the Human Skin and their Responses. (London: Shaw)
Itkin, I H. (1967). Bronchial hypersensitivity to mecholyl and histamine in asthma subjects. J. Allergy, 40, 245
Mathé, A. and Hedqvist, P. (1975). Effect of prostaglandins F2αand E2 on airway conductance in healthy subjects and asthmatic patients. Am. Rev. Resp. Dis., 111, 313
McLean, J. A., Mathews, K. P., Solomon, W. R., Brayton, P. R. and Ciarkowski, A. A. (1977). Effect of histamine and methacholine on nasal airway resistance in atopic and non-atopic subjects. J. Allergy Clin. Immunol., 59, 165
Henderson, W. R., Shelhamer, J. H., Reingold, D. B., Smith, L. J., Evans, R. and Kaliner, M. (1979). Alpha adrenergic hyper-responsiveness in asthma. Analysis of vascular and pupillary responses. N. Engl. J. Med., 300, 642
Vugman, L and Rocha e Silva, M. (1966). Biological determination of histamine in living tissues and body fluid. In Rocha e Silva, M. (ed.) Handbook of Experimental Pharmacology, Vol. XVIII/l, p. 81
Kaplan, A. P., Gray, L., Staff, R. E., Horakowa, Z. and Beaven, M. A. (1975). In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J. Allergy Clin. Immunol., 55, 394
Lichtenstein, L. M. and Gillespie, E. (1973). Inhibition of histamine release by histamine is controlled by an H2 receptor. Nature (London), 244, 287
Lichtenstein. L. M. and Gillespie, E. (1975). The effects of the H1 and H2 antihistamines on ‘allergic ’ histamine release and its inhibition by histamine. J. Pharmacol. Exper. Ther., 192, 441
Nogrady, S. G. and Bevan. C. (1978). Inhaled antihistamines — bronchodilatation and effects on histamine — and methacholine-induced bronchoconstriction. Thorax. 33, 700
Blackwell. G. J., Flower. R. J., Nijkamp, F. P. and Vane. J. R. (1978). Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-inflammatory steroids. Br. J. Pharmacol., 62, 79
Greene, L. J., Camargo, A. C. M., Kreiger, E. M., Stewart. J. M. and Ferreira. S. H. (1972). Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jacaraca venom. Circ. Res., 30 (Suppl. II). 62
Newball, H. H., Talamo, R. C. and Lichtenstein, L. M. (1975). Release of leucocyte kallikrein mediated by IgE. Nature (London), 254, 635
Eccles, R. and Wilson. H. (1973). A kallikrein-like substance in cat nasal secretion. Br. J. Pharmacol., 49, 711
Dolovich, J., Bach, N. and Arbesman, C. E. (1970). Kinin-like activity in nasal secretions of allergic patients. Int. Arch. Allergy, 38, 337
Abe. K., Watanabe. N., Kumagai, N., Mouri. T., Seki. T. and Yoshinaga, K. (1967). Circulating plasma kinin in patients with bronchial asthma. Experienttia (Basel), 23, 626
Herxheimer, H. and Streseman. E. (1963). Bradykinin and ethanol in bronchial asthma. Arch. Int. Pharmacodyn., 144, 315
Black, A. K., Greaves. M. W., Hensby, C. N. and Plummer, N. A. (1977). A method of obtaining human skin inflammatory exudate for pharmacological analysis. Br. J. Pharmacol., 58, 317
Goetzl, E. J. and Austen, K. F. (1975). Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc. Natl. Acad. Sci. USA, 72, 4123
Siraganian, R. P. and Hook, W. A. (1976). Complement-induced release from human basophils II. Mechanism of the histamine release reaction. J. Immunol., 116, 639
Garcia-Laem, J. and Hamamura, L. (1974). Formation of a factor increasing vascular permeability during electrical stimulation of the saphenous nerve in rats. Br. J. Pharmacol., 51, 383
Flower, R. J. and Blackwell, G. J. (1979). Anti inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature (London). 278, 456
Dray, F., McCall, E. and Youlten, L. J. F. (1980). Failure of anti inflammatory steroids to inhibit the production of prostaglandins by rat polymorphonuclear leucocytes. Br. J. Pharmacol. (In press)
Lichtenstein, L. M., Gillespie, E., Bourne, H. R. and Henney, C. S. (1972). The effects of a series of prostaglandins on in vitro models of the allergic response and cellular immunity. Prostaglandins, 2, 579
Szczeklik, A., Gryglewski, R. J. and Czerniawska-Mysik, G. (1975). Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J., 1, 61
Buisseret. P. D., Youlten. L. J. F., Heinzelmann. D. I. and Lessof. M. H. (1978). Prosta-glandin-synthesis inhibitors in prophylaxis of food intolerance. Lancet. 1, 906
Änggard, A. (1969). The effect of prostaglandins on nasal airway resistance in man. Ann. Otol. Rhinol. Laryngol., 78, 657
Murphy, R. C., Hammarström, S. and Samuelsson, B. (1979). Leuktriene C: a slow reacting substance from mouse mastocytoma cells. Proc. Natl. Acad. Sci. USA, 76, 4275
Augstein, J., Farmer, J. B., Lee, T. B., Sheard, P. and Tattersall, M. L. (1973). Selective inhibition of slow reacting substance of anaphylaxis. Nature (London) New Biol, 245, 215
Howell, J. B. L. and Altounyan, R. E. C. (1967). A double blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet, 2, 539
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 MTP Press Limited
About this chapter
Cite this chapter
Youlten, L.J.F. (1981). Pharmacological Mediators of Allergy. In: Lessof, M.H. (eds) Immunological and Clinical Aspects of Allergy. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6217-3_2
Download citation
DOI: https://doi.org/10.1007/978-94-011-6217-3_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6219-7
Online ISBN: 978-94-011-6217-3
eBook Packages: Springer Book Archive